On which types of pharmacy claims must hematocrit or hemoglobin readings be reported?


Effective January 1, 2008, the following claims must report the most recent hematocrit or hemoglobin reading for all claims billing for the administration of:

  • Erythropoiesis-stimulating agents (ESA) (J0881, J0882, J0885, J0886 and Q4081)
  • A Part B anti-anemia drug (other than ESAs) used in the treatment of cancer that are not self-administered.

For institutional claims the hemoglobin reading is reported with a value code 48 and a hematocrit reading is reported with the value code 49. Claims not reporting a value code 48 or 49 will be returned to the provider, according to section 80.8, chapter 17, Medicare Claims Processing Manual.


CPT® copyright 2021 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.